共 139 条
[1]
Corrin B(1975)Pulmonary lymphangiomyomatosis. A review Am J Pathol 79 348-382
[2]
Liebow AA(2001)Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex Am J Respir Crit Care Med 164 669-671
[3]
Friedman PJ(2021)Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management Lancet Respir Med 9 1313-1327
[4]
Moss J(2019)The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis Chest 155 288-296
[5]
Avila NA(2008)Sporadische lymphangioleiomyomatose Dtsch Med Wochenschr 133 705-708
[6]
Barnes PM(2004)Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone Chest 126 1867-1874
[7]
Litzenberger RA(1999)Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment Am J Respir Crit Care Med 160 628-633
[8]
Bechtle J(2016)Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis diagnosis and management Am J Respir Crit Care Med 194 748-761
[9]
Brooks PG(2021)Educational aspects of rare and orphan lung diseases Respir Res 22 92-1160
[10]
McCarthy C(2020)How do people in Germany seek health information? Insights from the first wave of HINTS Germany Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 63 1151-55